Green, Ari J.

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology

Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances

Cited by 807

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Cree, B. A. C., Bennett, J. L., Kim, H. J., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., Fujihara, K., Paul, F., Cutter, G. R., Marignier, R., et al. (2019) · The Lancet

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 756

Multiple sclerosis progression: time for a new mechanism-driven framework

Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 667

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife

Computational Drug Discovery MethodsBiomedical Text Mining and Ontologies

Cited by 666

The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment

Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., & Petzold, A. (2012) · PLoS ONE

Multiple Sclerosis Research StudiesRetinal Imaging and Analysis

Cited by 627

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Green, A. J., Gelfand, J. M., Cree, B. A., Bevan, C., Boscardin, W. J., Mei, F., Inman, J., Arnow, S., Devereux, M., Abounasr, A., et al. (2017) · The Lancet

Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanisms

Cited by 593

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

Montalban, X., Lebrun-Frénay, C., Oh, J., Arrambide, G., Moccia, M., Pia Amato, M., Amezcua, L., Banwell, B., Bar-Or, A., Barkhof, F., et al. (2025) · The Lancet Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 551

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., et al. (2009) · Human Molecular Genetics

Multiple Sclerosis Research StudiesGenetic Associations and Epidemiology

Cited by 476

Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation

Mendiola, A. S., Ryu, J. K., Bardehle, S., Meyer-Franke, A., Ang, K. K.-H., Wilson, C., Baeten, K. M., Hanspers, K., Merlini, M., Thomas, S., et al. (2020) · Nature Immunology

Neuroinflammation and Neurodegeneration MechanismsMultiple Sclerosis Research Studies

Cited by 199

Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis

Ward, M. E., Chen, R., Huang, H.-Y., Ludwig, C., Telpoukhovskaia, M., Taubes, A., Boudin, H., Minami, S. S., Reichert, M., Albrecht, P., et al. (2017) · Science Translational Medicine

Lysosomal Storage Disorders ResearchAmyotrophic Lateral Sclerosis Research

Cited by 193

Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study

Paul, F., Calabresi, P. A., Barkhof, F., Green, A. J., Kardon, R., Sastre‐Garriga, J., Schippling, S., Vermersch, P., Saidha, S., Gerendas, B. S., et al. (2021) · Annals of Clinical and Translational Neurology

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 98

The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis

Saidha, S., Green, A. J., Leocani, L., Vidal-Jordana, A., Kenney, R. C., Bsteh, G., Outteryck, O., Thompson, A., Montalban, X., Coetzee, T., et al. (2025) · The Lancet Neurology

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 66

Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal Cohort

Oertel, F. C., Krämer, J., Motamedi, S., Keihani, A., Zimmermann, H. G., Dimitriou, N. G., Condor-Montes, S., Bereuter, C., Cordano, C., Abdelhak, A., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 33

Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores

Lin, T.-Y., Motamedi, S., Asseyer, S., Chien, C., Saidha, S., Calabresi, P. A., Fitzgerald, K. C., Samadzadeh, S., Villoslada, P., Llufriu, S., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 12